These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22835733

  • 1. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T, Sato A, Nishina H, Kakefuda Y, Wang Z, Noguchi Y, Aonuma K.
    J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
    Harasawa R, Hayashi Y, Iwasaki M, Kamibayashi T, Mashimo T.
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
    [Abstract] [Full Text] [Related]

  • 4. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
    Park H, Otani H, Noda T, Sato D, Okazaki T, Ueyama T, Iwasaka J, Yamamoto Y, Iwasaka T.
    Int J Cardiol; 2013 Aug 20; 167(4):1547-51. PubMed ID: 22608892
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
    Tokunaga C, Hiramatsu Y, Kanemoto S, Takahashi-Igari M, Abe M, Horigome H, Sakakibara Y.
    Ann Thorac Surg; 2013 May 20; 95(5):1685-8. PubMed ID: 23506630
    [Abstract] [Full Text] [Related]

  • 7. The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.
    Sugiura S, Seki S, Hidaka K, Masuoka M, Tsuchida H.
    Anesth Analg; 2007 Jan 20; 104(1):124-9. PubMed ID: 17179256
    [Abstract] [Full Text] [Related]

  • 8. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T, Shimizu K, Kawashima O, Kamiyoshihara M, Nagashima T, Ibe T, Takeyoshi I.
    J Clin Pharm Ther; 2012 Aug 20; 37(4):431-5. PubMed ID: 22059486
    [Abstract] [Full Text] [Related]

  • 9. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S, Murakami W, Myoren T, Tateishi H, Okuda S, Doi M, Nao T, Wada Y, Matsuzaki M, Yano M.
    Cardiology; 2014 Aug 20; 127(2):105-13. PubMed ID: 24296610
    [Abstract] [Full Text] [Related]

  • 10. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Hanada K, Higuma T, Nishizaki F, Sukekawa T, Yokota T, Yamada M, Saito S, Kushibiki M, Oikawa K, Abe N, Tomita H, Osanai T, Okumura K.
    Circ J; 2012 Aug 20; 76(2):439-45. PubMed ID: 22156314
    [Abstract] [Full Text] [Related]

  • 11. [Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting].
    Iwasawa K, Nakagawa H, Katou M, Yonezawa K, Nishizawa M, Yanagiya N.
    Masui; 2005 Apr 20; 54(4):402-7. PubMed ID: 15852628
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
    Hirota K, Baba S, Fukushi S, Muraoka M, Matsuki A.
    J Anesth; 2005 Apr 20; 19(1):17-20. PubMed ID: 15674510
    [Abstract] [Full Text] [Related]

  • 13. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
    Adachi T, Sato A, Baba M, Hiraya D, Hasegawa T, Kuroki K, Hoshi T, Aonuma K.
    Heart Vessels; 2014 Jul 20; 29(4):464-9. PubMed ID: 23801459
    [Abstract] [Full Text] [Related]

  • 14. Continuous administration of landiolol reduced QT dispersion in postoperative patients.
    Suzuki K, Numaguchi A, Adachi YU, Obata Y, Hatano T, Ejima T, Sato S, Matsuda N.
    J Clin Anesth; 2014 Sep 20; 26(6):438-42. PubMed ID: 25204509
    [Abstract] [Full Text] [Related]

  • 15. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
    Maisawa K, Yamazaki K, Ishitoya H, Shimamura Y.
    Asian Cardiovasc Thorac Ann; 2013 Apr 20; 21(2):170-5. PubMed ID: 24532615
    [Abstract] [Full Text] [Related]

  • 16. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
    Taenaka N, Kikawa S.
    Am J Cardiovasc Drugs; 2013 Oct 20; 13(5):353-64. PubMed ID: 23818039
    [Abstract] [Full Text] [Related]

  • 17. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S, Yamashita K, Nishimori H, Fukutomi T, Yamamoto M, Radhakrishnan G, Sasaguri S.
    Interact Cardiovasc Thorac Surg; 2009 Nov 20; 9(5):811-3. PubMed ID: 19666952
    [Abstract] [Full Text] [Related]

  • 18. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
    Takahashi S, Fujii Y, Hoshi T, Inomata S, Miyabe M, Toyooka H.
    Can J Anaesth; 2000 Mar 20; 47(3):265-72. PubMed ID: 10730740
    [Abstract] [Full Text] [Related]

  • 19. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
    Kurosawa S, Kanaya N, Niiyama Y, Nakayama M, Fujita S, Namiki A.
    Can J Anaesth; 2003 May 20; 50(5):489-94. PubMed ID: 12734159
    [Abstract] [Full Text] [Related]

  • 20. Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
    Sakamoto A, Ogawa R, Suzuki H, Kimura M, Okubo Y, Fujiya T.
    Psychiatry Clin Neurosci; 2004 Dec 20; 58(6):630-5. PubMed ID: 15601388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.